Fortive Corp (FTV)

How it makes money

Revenue comes partly from one-off sales of instruments and capital equipment through distributors and a direct sales force, and partly from a recurring stream: consumables and service contracts tied to an installed base (notably sterilization consumables and dosimetry badge services), plus software sold on subscription or licence with maintenance. At the 2025 separation Fortive described the remaining company as having roughly 50% recurring revenue; the 10-K itself does not restate that figure. The 10-K notes that capital equipment and sterilization consumable sales are often stronger in the fourth calendar quarter, but that the company as a whole is not subject to material seasonality.

Revenue by segment

Fortive's own filing says management believes the company holds a market leadership position in most of the markets it serves, and it markets through long-established professional brands — Fluke, Industrial Scientific, ASP, Landauer — where brand name recognition is listed among the key competitive factors, alongside price, quality, applications expertise, distribution channel access and service. Part of the revenue is attached to an installed base of equipment that consumes proprietary consumables and service, which tends to make the relationship sticky. The filing does not quantify switching costs, market shares or barriers to entry, and it describes competition as intense in every business, so the advantage should be read as real but not fortress-like.

Demand splits in two. The larger Intelligent Operating Solutions segment sells tools and instruments used in maintenance and repair, which follows industrial activity and maintenance budgets more than new plant construction, and software for facilities and assets that renews; it is exposed to the industrial cycle but cushioned by replacement and consumable demand. Advanced Healthcare Solutions follows hospital procedure volumes and capital budgets, which are steadier through a downturn, though equipment purchases can be deferred. Fortive's own risk factors name the growth rate and cyclicality of its markets as a risk; the 10-K says capital equipment and sterilization consumable sales are often stronger in the fourth calendar quarter but that the company as a whole is not subject to material seasonality.

Key risks

• Global economy and end-market conditions — Fortive lists conditions in the global economy, in the markets it serves and in financial markets as able to adversely affect its business and results, and separately flags the growth rate and cyclicality of those markets as a risk.
• Supply chain, manufacturing capacity and input costs — The company cites challenges in managing manufacturing capacity and its supply chain, and fluctuations in the cost of commodities and components, as risks to its cost structure and ability to deliver.
• Competition and dependence on new products — Fortive discloses that it faces intense competition and that its results depend on successfully developing and launching new products and software; failure to innovate at the pace of its markets is listed as a risk.
• Cybersecurity and product defects — Risk factors cover cybersecurity incidents and data breaches — relevant for a business selling connected devices and clinical software — as well as product defects and the resulting liability and recall exposure.
• Healthcare and environmental regulation — Compliance with healthcare regulation, with changing industry standards and with environmental, health and safety requirements is disclosed as a risk, as are liabilities arising from those requirements.
• Acquisitions, divestitures and separation-related liabilities — Fortive flags execution risk in its capital allocation, acquisitions and integrations, contingent liabilities retained from divestitures, indemnification obligations linked to Ralliant and Vontier, and the tax risks arising from the separation transactions.
• International operations, trade and currency — The filing lists the risks of operating internationally, volatility in trade relations, and adverse movements in foreign currency exchange rates.
• Goodwill impairment and debt — Because Fortive has grown by acquisition, it discloses the risk of impairment of goodwill and other intangible assets, along with risks tied to its debt obligations and access to financing.

The 10-K does not disclose a customer concentration figure: there is no statement that any single customer accounted for 10% or more of sales, and no top-customers share is given. Fortive describes selling through a combination of direct sales forces and distributors and channel partners to a broad base of industrial, utility, government and healthcare customers, and lists the loss of distributor and channel partner relationships — not the loss of a single end customer — among its risk factors.